Skip to Content

CD 129 (Ranitidine Hydrochloride 150 mg)

Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CD 129

Ranitidine hydrochloride 150 mg CD 129 Front
Ranitidine hydrochloride 150 mg CD 129 Back
Ranitidine hydrochloride 150 mg CD 129
Ranitidine hydrochloride 150 mg CD 129

Ranitidine Hydrochloride

Imprint
CD 129
Strength
150 mg
Color
Brown
Size
15.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, titanium dioxide, gelatin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
55111-0129 Dr. Reddy's Laboratories, Inc.
42291-0735 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.